How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

2,214 results for

New Daily Persistent Headache

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. An RCVS Spectrum Disorder? New Daily Persistent Headache Starting as a Single Thunderclap Headache (3 New Cases). (PubMed)

An RCVS Spectrum Disorder? New Daily Persistent Headache Starting as a Single Thunderclap Headache (3 New Cases). To describe 3 new cases of new daily persistent headache (NDPH) starting as a single thunderclap headache.NDPH is a form of chronic daily headache that is unique in its temporal profile of onset. Distinct subtypes of NDPH are being described with specific efficacious treatments. A single case of NDPH starting as a single thunderclap headache has been previously reported (...) but no further cases have been documented in the literature. New cases need to be published to better define the syndrome.To report a case series of patients diagnosed with this unique NDPH subtype at an academic headache center from 2016 to 2018.Three new cases of NDPH starting as a single thunderclap headache at onset were diagnosed. All patients were female with an average age of onset of 46 years. All presented with neurologic symptoms/stroke-like spells at headache onset. No defined triggering events

2019 Headache

2. Endogenous Modulation and Central Sensitization in New Daily Persistent Headache ( NDPH ) in Children

Endogenous Modulation and Central Sensitization in New Daily Persistent Headache ( NDPH ) in Children Endogenous Modulation and Central Sensitization in New Daily Persistent Headache ( NDPH ) in Children - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please (...) remove one or more studies before adding more. Endogenous Modulation and Central Sensitization in New Daily Persistent Headache ( NDPH ) in Children (EMCS-NDPH) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03447782

2018 Clinical Trials

3. New Daily Persistent Headache: Historical Review and an Interview with Dr. Walter Vanast. (PubMed)

New Daily Persistent Headache: Historical Review and an Interview with Dr. Walter Vanast. New daily persistent headache (NDPH) is an idiopathic headache syndrome characterized by the abrupt onset of an unremitting, daily, continuous headache without an antecedent escalating headache pattern, and not attributable to other primary or secondary headache disorders. We review the history of NDPH in terms of its characterization and classification, and then interview Dr. Walter Vanast (...) , the neurologist who initially described NDPH three decades ago, to gain his perspective now that there is more widespread recognition and interest in this syndrome.© 2017 American Headache Society.

2017 Headache

4. Psychiatric comorbidity in new daily persistent headache: A cross-sectional study. (PubMed)

Psychiatric comorbidity in new daily persistent headache: A cross-sectional study. New daily persistent headache (NDPH) is a type of chronic daily headache. NDPH can have migrainous (NDPH-CM) or tension-type character (NDPH-CTTH). Recently, NDPH patients have shown to have associated anxiety and depression. We compared anxiety, depressive symptoms, somatization and pain catastrophization among NDPH, healthy controls and patients with chronic low-back pain and between NDPH-CM and NDPH-CTTH.We (...) individuals and patients with chronic low back pain. Such effects should be sought for, as they might contribute to refractoriness to treatment.Anxiety, depressive symptoms, somatization and pain catastrophizing were significantly more prevalent in new daily persistent headache when compared to healthy individuals and patients with chronic low back pain. Such effects should be sought for, as they might contribute to refractoriness to treatment.© 2017 European Pain Federation - EFIC®.

2017 European Journal of Pain

5. New Daily Persistent Headache Caused by a Multinodular Goiter and Headaches Associated With Thyroid Disease. (PubMed)

New Daily Persistent Headache Caused by a Multinodular Goiter and Headaches Associated With Thyroid Disease. A 33-year-old female is presented with the first case to our knowledge of new daily persistent headache (NDPH) with a large right benign non-toxic multinodular goiter causing carotid and vertebral compression with complete resolution of the headache immediately after thyroidectomy. Although this may be quite rare, hypothyroidism or hyperthyroidism causing NDPH, migraine (...) , or an exacerbation of pre-existing migraine is not. Clinicians should consider routinely obtaining serum thyroid-stimulating hormone (TSH) and free T4 in patients with new onset frequent headaches or an exacerbation of prior primary headaches.© 2016 American Headache Society.

2016 Headache

6. New Daily Persistent Headache

New Daily Persistent Headache New Daily Persistent Headache Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 New Daily Persistent (...) Headache New Daily Persistent Headache Aka: New Daily Persistent Headache From Related Chapters II. Symptoms Characteristics Pressing, tightening Region Bilateral involvement Timing Constant and unremitting in the first 3 days and then persists Contrast with or that may be become constant over a longer period of time Duration longer than 3 days from onset Occurs daily for >3 months Provocative factors Not worse with exertion (contrast with ) No associated autonomic symptoms (contrast with and other

2018 FP Notebook

7. Triggering Events and New Daily Persistent Headache: Age and Gender Differences and Insights on Pathogenesis-A Clinic-Based Study. (PubMed)

Triggering Events and New Daily Persistent Headache: Age and Gender Differences and Insights on Pathogenesis-A Clinic-Based Study. To define what are the age and gender differences for new daily persistent headache (NDPH) triggering events and how this may relate to the pathogenesis of NDPH. To describe several new triggering events for NDPH.All patients were diagnosed with primary NDPH at a headache specialty clinic during the time period of 01/2009 through 01/2013. This was a retrospective (...) of the NDPH patients who developed new onset headache after an invasive surgical procedure were intubated. There was no significant difference in frequency for any of the triggering events between genders. The youngest age of onset was for a post stressful life event trigger while the oldest age of onset was in the post-surgical subgroup. Women developed NDPH at a younger age of onset for all recognized triggers, but there was no significant difference in ages of onset between the genders

2015 Headache

8. Chronic Daily Headache and Medication Overuse Headache in First-Visit Headache Patients in Korea: A Multicenter Clinic-Based Study (PubMed)

, 8.8%), chronic tension-type headache (CTTH) (98, 6%), and definite new daily persistent headache (NDPH) (7, 0.4%). MOH was associated with headache in 81 patients (5%). The association with MOH was stronger among CM patients (34.5%) than patients with CTTH (13.3%) or NDPH (14.3%) (p=0.001). The frequency of CDH did not differ between secondary and tertiary referral hospitals.The frequencies of CDH and MOH diagnoses were 15.2% and 5%, respectively in first-visit headache patients presented (...) Chronic Daily Headache and Medication Overuse Headache in First-Visit Headache Patients in Korea: A Multicenter Clinic-Based Study Chronic daily headache (CDH) is defined as a headache disorder in which headaches occur on a daily or near-daily basis (at least 15 days/month) for more than 3 months. Chronic migraine (CM) and medication overuse headache (MOH) are very disabling headaches that remain underdiagnosed. The aim of this study was to establish the frequency of CDH and its various

Full Text available with Trip Pro

2016 Journal of clinical neurology (Seoul, Korea)

9. Mexiletine for refractory chronic daily headache: a report of nine cases. (PubMed)

with a chronic daily headache, including chronic migraine or new daily persistent headache, with significant clinical improvement while using mexiletine as a headache preventative. Each patient had failed to respond to multiple preventative and acute treatments. Seven of the 9 rated mexiletine "much more effective" and 2 "more effective" than previous preventative headache medications. The daily dose ranged from 600 mg/day to 1500 mg/day. Side effects were common and occurred in 7 patients. The majority (...) Mexiletine for refractory chronic daily headache: a report of nine cases. To describe the use of mexiletine in the treatment of chronic daily headache in a refractory headache population.Intravenous lidocaine is a novel treatment for chronic daily headache with medication overuse and SUNCT syndrome. Mexiletine is a similar but orally active anti-arrhythmic that has been demonstrated to be an effective analgesic in various types of neuropathic pain. We looked at mexiletine as a preventative

2017 Headache

10. Assessment of acute headache in children

Society (IHS). The international classification of headache disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211. https://www.ichd-3.org/ http://www.ncbi.nlm.nih.gov/pubmed/29368949?tool=bestpractice.com Primary headaches include migraine, tension-type, cluster, as well as the new daily persistent headache. Secondary headaches are symptomatic of an underlying intracranial or medical condition that requires treatment. The initial assessment of acute headache aims to determine whether (...) ) Cerebral sinovenous thrombosis Postconcussion headache Cerebral contusion Subdural haemorrhage Intracranial hypotension Epidural haemorrhage Meningitis Encephalitis Dental caries, gingival disease, or abscess Brain tumour Temporomandibular joint syndrome Tension headache Indometacin-responsive headache Medication-overuse headache Cluster headache New daily persistent headache Intermittent hydrocephalus Pseudotumour cerebri (idiopathic intracranial hypertension) Ventriculoperitoneal shunt dysfunction

2018 BMJ Best Practice

11. Headache

, an invasive procedure frequently performed in the emergency room. Numerous pharmaceutical drugs have been proposed to treat PDPH but there are still some uncertainties about their clinical (...) pharmacological drug used for treating PDPH. Outcome measures considered for this review were: PDPH persistence of any severity at follow-up (primary outcome), daily activity limited by headache , conservative supplementary therapeutic option offered, epidural blood patch performed, change in pain severity scores (...) Migraine is a chronic, genetically determined, episodic, neurological disorder that usually presents in early-to-mid life. Patients complain of intermittent headache and associated symptoms 2018 13. Treatment of Cluster Headache : The American Headache Society Evidence-Based Guidelines. BACKGROUND: Cluster headache (CH), the most common trigeminal autonomic cephalalgia , is an extremely debilitating primary headache disorder that is often not optimally treated. New evidence-based treatment guidelines

2018 Trip Latest and Greatest

12. Headache

not necessarily imply individual or society endorsement of the final document. Reprint requests to: publications@acr.org ACR Appropriateness Criteria ® 11 Headache emphasized that the costs of detection or screening in imaging headache are always overstated when the value of negative results is not factored into the analysis [15,19]. Chronic Headache, No New Features and Normal Neurologic Examination Chronic daily headache represents a range of disorders characterized by the occurrence of long-duration (...) of headache or populations at risk, neuroimaging procedures are more likely to be positive. Examples of headaches for which imaging procedures may be helpful include headaches associated with head and neck trauma; new, worse, or abrupt-onset headache; thunderclap headache; headache radiating to the neck; trigeminal autonomic cephalgia, persistent positional headache; and temporal headache in older individuals. Pregnant patients, immunocompromised individuals, cancer patients, and patients with papilledema

2019 American College of Radiology

13. OnabotulinumtoxinA for the Treatment of New Daily Persistent Headache: an Open Label Study

OnabotulinumtoxinA for the Treatment of New Daily Persistent Headache: an Open Label Study OnabotulinumtoxinA for the Treatment of New Daily Persistent Headache: an Open Label Study - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more (...) studies before adding more. OnabotulinumtoxinA for the Treatment of New Daily Persistent Headache: an Open Label Study The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01920945 Recruitment Status : Terminated (Difficult enrollment) First Posted : August 12, 2013 Last Update Posted : October 26, 2016

2013 Clinical Trials

14. New daily persistent headache (PubMed)

New daily persistent headache New daily persistent headache (NDPH) is a chronic headache developing in a person who does not have a past history of headaches. The headache begins acutely and reaches its peak within 3 days. It is important to exclude secondary causes, particularly headaches due to alterations in cerebrospinal fluid (CSF) pressure and volume. A significant proportion of NDPH sufferers may have intractable headaches that are refractory to treatment. The condition is best viewed (...) as a syndrome rather than a diagnosis. The headache can mimic chronic migraine and chronic tension-type headache, and it is also important to exclude secondary causes, particularly headaches due to alterations in CSF pressure and volume. A large proportion of NDPH sufferers have migrainous features to their headache and should be managed with treatments used for treating migraine. A small group of NDPH sufferers may have intractable headaches that are refractory to treatment.

Full Text available with Trip Pro

2012 Annals of Indian Academy of Neurology

15. New Daily Persistent Headache

New Daily Persistent Headache New Daily Persistent Headache Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 New Daily Persistent (...) Headache New Daily Persistent Headache Aka: New Daily Persistent Headache From Related Chapters II. Symptoms Characteristics Pressing, tightening Region Bilateral involvement Timing Constant and unremitting in the first 3 days and then persists Contrast with or that may be become constant over a longer period of time Duration longer than 3 days from onset Occurs daily for >3 months Provocative factors Not worse with exertion (contrast with ) No associated autonomic symptoms (contrast with and other

2015 FP Notebook

16. CRACKCast E103 – Headache Disorders

IV or 30 to 60 mg IM Gastrointestinal upset; avoid this medication in elderly and in patients with renal insufficiency Second Line Agents: Morphine 4 to 8 mg IM or IV Opioids less efficacious than other treatment modalities Magnesium 2 g IV More efficacious in migraine with aura Valproic acid 1 g IV Contraindicated in pregnancy 5) List four migraine variants. Neuroimaging should be considered for older or immunocompromised patients with new-onset headaches, headaches associated with unexplained (...) . The progression of the motor deficit is gradual and in most cases is accompanied by a visual, sensory, or speech disturbance. The neurologic symptoms last up to 60 minutes, followed by headache. Rarely, the motor deficit is persistent, resulting from a true migrainous stroke. A familial version of hemiplegic migraine is associated with genetic Migraine with brainstem aura An aura referable to the brainstem. Common neurologic findings include dysarthria, tinnitus, vertigo, diplopia, and altered level

2017 CandiEM

17. New daily persistent headache: clinical perspective. (PubMed)

New daily persistent headache: clinical perspective. New daily persistent headache is a recognized form of primary chronic daily headache. It is unique in its presentation and course. The goal of this article is to discuss the clinical characteristics, triggering factors, possible underlying pathogenesis and treatment options for this unique headache disorder. At present prognosis for new daily persistent headache is considered poor with very few effective treatment options. A new treatment (...) paradigm for new daily persistent headache based on triggering events will be suggested. The current International Classification of Headache Disorders 2 criteria for new daily persistent headache will also be discussed including its apparent inadequacies and revised criteria will be recommended.© 2011 American Headache Society.

2011 Headache

18. New daily persistent headache: a syndrome not a discrete disorder. (PubMed)

New daily persistent headache: a syndrome not a discrete disorder. The term New Daily Persistent Headache (NDPH) has been used for nearly 25 years and yet the entity remains enigmatic. It can be argued the simplest, indeed most appropriate, approach is to use the term to mean simply what it says- i.e. as an umbrella description, rather like chronic daily headache. NDPH should be used as a diagnostic umbrella inviting better characterization, not be an achievement in itself. This would mean (...) headaches can be seen in practice and in the literature and these should be sub-divided into a migrainous type, with appropriate phenotypic manifestations and a featureless type. Patients with any one of the NDPH presentations are best managed according to the more detailed pathophysiology-based diagnosis then lumped together into a single group, since a single disorder is unlikely to exist.© 2011 American Headache Society.

2011 Headache

19. A Survey of Headache Medicine Physicians on the Likeability of Headaches and Their Personal Headache History. (PubMed)

), chronic migraine (CM), refractory migraine (RM), episodic cluster (EC), chronic cluster (CC), new daily persistent headache (NDPH), and postconcussion syndrome (PCS)."The response rate was 15.8% (n = 118) with a mean age of 51.4 years, 64.4% males, and 85.6% neurologists. HMS reported likeability for treating disorders in rank order as follows: EM (mean = 4.69, SD = 0.61); CM (mean = 4.20, SD = 0.94); RM (mean = 3.62, SD = 1.17); EC (mean = 4.37, SD = 0.80); CC (mean = 3.68, SD = 1.10); NDPH (mean (...) A Survey of Headache Medicine Physicians on the Likeability of Headaches and Their Personal Headache History. Two prior studies have shown an increased prevalence of migraine among physicians who are headache medicine specialists (HMS). There have been no studies of the prevalence of other headache disorders among HMS. A prior survey showed that neurologists like to treat some headaches more than others but there has not been a similar survey of HMS.The aim of the survey was to learn more about

2016 Headache

20. Is Procardia XL 60 mg Q Daily Equivalent to 30 mg XL Given Twice Daily?

Is Procardia XL 60 mg Q Daily Equivalent to 30 mg XL Given Twice Daily? Is Procardia XL 60 mg Q Daily Equivalent to 30 mg XL Given Twice Daily? - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Is Procardia (...) XL 60 mg Q Daily Equivalent to 30 mg XL Given Twice Daily? The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03595982 Recruitment Status : Recruiting First Posted : July 23, 2018 Last Update Posted : March 8, 2019 See

2018 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>